Low-density lipoprotein receptor 6 (LRP6) as a mammary stem...

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

07622267

ABSTRACT:
A method for enriching a population of somatic mammary stem cells or mammary tumor stem cells based on low-density lipoprotein receptor-related protein 6 (LRP6). Also included are methods for screening for LRP6 modulators, as well as methods for reducing Wnt signaling, for treating Wnt signaling-related diseases, for detecting mammary basal-like cells, for diagnosing basal-like breast cancer, and for inhibiting proliferation of a tumor expressing LRP6, and compositions thereof.

REFERENCES:
patent: 2006055635 (2006-05-01), None
patent: 2007140410 (2007-12-01), None
Tockman et al (Cancer Res., 1992, 52:2711s-2718s).
Benhajk et al (Oncology Reports, 2006, 15:701-707).
Al-Hajj M, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci 100, No. 7: 3983-3988; (Apr. 1, 2003).
Li Y, et al. Evidence that transgenes encoding components of the Wnt signaling pathway preferentially induce mammary cancers from progenitor cells. Proc Natl Acad Sci 100, No. 26: 15853-15858 (Dec. 23, 2003).
Liu B, et al. The transforming activity of Wnt effectors correlates with their ability to induce the accumulation of mammary progenitor cells. Proc Natl Acad Sci 101, No. 12: 4158-4163 (Mar. 23, 2004).
Reya T, et al. A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature 423: 409-414 (May 22, 2003).
Shackleton M, et al. Generation of a functional mammary gland from a single stem cell. Nature 439: 84-88 (Jan. 5, 2006).
Stingl J, et al. Purification and unique properties of mammary epithelial stem cells. Nature 439: 993-997 (Feb. 23, 2006).
Veltmaat J, et al. Mouse embryonic mammogenesis as a model for the molecular regulation of pattern formation. Differentiation 71: 1-17 (2003).
Benhaj K, et al. Redundant expression of canonical Wnt ligands in human breast cancer cell lines. Oncology Reports 15: 701-707 (2006).
Katoh M, et al. Cross-talk of WNT and FGF Signaling Pathways at GSK3β to Regulate β-Catenin and SNAIL Signaling Cascades. Cancer Biology & Therapy 5 (No. 9): 1059-1064 (Sep. 2006).
Khan Z, et al. Analysis of Endogenous LRP6 Function Reveals a Novel Feedback Mechanism by Which Wnt Negatively Regulates Its Receptor. Molecular and Cellular Biology 27 (No. 20): 7291-7301 (Oct. 2007).
He X, understanding Wnt/beta-catenin signaling. FASEB J. 20 (Abstract 862.1): A1337 (2006).
Lindvall C, et al. The Wnt Signaling Receptor Lrp5 Is Required for Mammary Ductal Stem Cell Activity and Wnt1-induced Tumorigenesis. The Journal of Biological Chemistry 281 (No. 46): 35081-35087. (Nov. 17, 2006).
Lindvall C, et al. Wnt Signaling, Stem Cells, and the Cellular Origin of Breast Cancer. Stem Cell Rev 3: 157-168 (2007).
Young J, et al. LRP5 and LRP6 Are Not Required for Protective Antigen-Mediated Internalization or Lethality of Anthrax Lethal Toxin. PLoS Pathogens 3 (No. 3): 0287-0295 (Mar. 2007).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Low-density lipoprotein receptor 6 (LRP6) as a mammary stem... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Low-density lipoprotein receptor 6 (LRP6) as a mammary stem..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Low-density lipoprotein receptor 6 (LRP6) as a mammary stem... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4058843

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.